Age: 32.0
Sex: F
Vaccine: PPV, FLU3, PPV
Symptoms: Blood test, Pyrexia, Vomiting
Clinical narrative: Initial unsolicited report received from a healthcare professional on 21 January 2015. A female patient, whose age, medical history and concomitant medications were not reported, had received FLUZONE, Manufacturer: Sanofi Pasteur Inc, Lot number: UI198AD, (dose, dose number, vaccine expiry date and site of administration were not reported) via intramuscular route on 8 January 2015, and received PNEUMOVAX 23, Manufacturer: Merck, Lot number: K009809, (dose, dose number, vaccine expiry date and site of administration were not reported) via intramuscular route on 8 January 2015. And also received second dose of influenza vaccine, (dose, Manufacturer, Lot number, vaccine expiry date and site of administration were not reported) via intramuscular route on 8 January 2015. On 9 January morning after vaccination it was reported that the patient had experienced symptoms like nausea, vomiting, and a temp of 101F. It was reported that the patient had received an influenza vaccine 3 weeks before this second dose was inadvertently administered. Patient was seen by her physician 24 hours after symptoms began, and was sent to the hospital for blood work and blood work data was not reported. It was reported that the patient required ER/doctor visit. Laboratory investigations includes blood work, results were not reported and corrective treatments were not reported. At the time of this report the patient outcome was unknown. Documents held by sender: none. Follow-up information from a health care professional on 17 April 2015. Patient age was updated to 33 years and contact information was updated. Patient has a medical history of Asthma. On 19 January 2015, the patient was administered with first dose of PNEUMOVAX 23 (batch number-K009809, expiry date: 16 May 2015) in right deltoid at 15 hours. The date of onset was updated as 19 January 2015. It was also reported that patient was given FLUZONE vaccine in error initially the patient had a flu shot a few weeks prior. The expiry date of FLUZONE vaccine updated as 30 June 2015. Responsible physician information was updated. The vaccine was administered at public health clinic/hospital. The patient reported temperature in the evening of vaccination along with nausea and vomiting. On 21 January 2015, patient was recovered from the events. Document held by sender: yes (vaccine adverse experience report). Follow-up information received from a nurse on 29 June 2015. A 32-years-old (age reported as 43-year-old) patient had received a FLUZONE, PNEUMOVAX 23 (in right deltoid) vaccine on 19 January 2015. The patient did not have illness at the time of vaccination and pre-existing physician diagnosed allergies, birth defects and medical conditions. On 20 January 2015, one day post-vaccination, the patient experienced nausea, vomiting and temperature of 101 Fahrenheit. It was reported that, the patient had received a "flu vaccine" within the past four weeks on 19 January 2015. Laboratory investigation includes, blood work which was performs on an unspecified date and result was not reported. The patient did not receive any treatment. List of documents held by sender: none.